Remdisivir – Page 2 – The COVID-19 Long Haul Foundation

Remdesivir for the Treatment of Covid-19 — Final Report

August 12, 2021 | John Murphy | Leave a Comment

Authors: John H. Beigel, M.D., Kay M. Tomashek, M.D., M.P.H., Lori E. Dodd, Ph.D., Aneesh K. Mehta, M.D., Barry S. Zingman, M.D., Andre C. Kalil, M.D., M.P.H., Elizabeth Hohmann, M.D., Helen Y. Chu, M.D., M.P.H., Annie Luetkemeyer, M.D., Susan…[...]

Severe covid-19 pneumonia: pathogenesis and clinical management

August 11, 2021 | John Murphy | Leave a Comment

Authors: Amy H Attaway, assistant professor of medicine, associate director, COPD center1, Rachel G Scheraga, assistant professor of medicine1 2, Adarsh Bhimraj, head, section of neurological infections; staff, infectious diseases1, Michelle…[...]